Assistance Publique - Hôpitaux de Paris: Pneumonia trials

The registry lists 29 Pneumonia studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 6No phase 21(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Immune Responses and Pulmonary Complications After Cardiac Surgery With Cardiopulmonary BypassNot yet recruitingNCT07865533
• Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clinical Treatment FailuresRecruitingNCT06916481
• Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired PneumoniaRecruitingNCT05903352Phase 3
• Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care UnitRecruitingNCT05696093Phase 3
• Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive CareRecruitingNCT05124977Not applicable
• Antibiotic Therapy In Respiratory Tract InfectionsNot yet recruitingNCT04166110Not applicable
• Study of the Characteristics of Acute Mycoplasma Resuscitation: ECRAN-PLASMA StudyActive, not recruitingNCT07479355
• Impact of Antibio Prophylaxis on Occurence of Ventilator Associated Pneumonia in Trauma PatientsCompletedNCT07059039
• Infectious Complications After EsophagectomyCompletedNCT06911658
• Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency RoomCompletedNCT05657275Not applicable
• RAPid SOlution for Diagnosis of Respiratory Infection in Pediatric Intensive Care UnitCompletedNCT04773704
• FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 PneumoniaCompletedNCT04618042Phase 2
• Myeloid Cells in Patients With Covid-19 PneumoniaWithdrawnNCT04590261Not applicable
• Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related PneumoniaCompletedNCT04357457Phase 3
• Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)Status unknownNCT04355429Phase 2
• Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 PneumoniaStatus unknownNCT04344730Not applicable
• Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare ProvidersStatus unknownNCT04341519
• Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 PneumoniaCompletedNCT04334850Not applicable
• Immune Alveolar Alterations During Pneumonia-Associated Acute Respiratory Distress SyndromeStatus unknownNCT03971006
• Multiplex Polymerase Chain Reaction in Postoperative Pneumonia After Thoracic SurgeryStatus unknownNCT03752320
• Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired PneumoniaCompletedNCT03452826Not applicable
• Nebulized and Intravenous Colistin in Ventilator Associated-pneumoniaTerminatedNCT02906722Phase 3
• Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia (iDIAPASON)CompletedNCT02634411Not applicable
• Empiric Antibiotic Therapy for Ventilator-acquired Pneumonia With Gram-negative Bacilli in Intensive CareStatus unknownNCT02127528
• Sellick Interest in Rapid Sequence InductionCompletedNCT02080754Phase 3
• Catheter Outcomes With Sternotomy Cardiac OperatedCompletedNCT01648777Phase 3
• Impact of Imipenem With Amikacin Pharmacokinetic and PharmacodynamicCompletedNCT00950222Not applicable
• Assessment of the Diagnostic Capacity of the Mini-broncho Alveolar Lavage Performed Through a Suction CatheterCompletedNCT00763620Not applicable
• Study to Evaluate Two Diagnostic Strategies for the Treatment of Severe Community Acquired Pneumonia (SCAP)Status unknownNCT00308659Not applicable